Page 20 - Umer Raffat News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Umer Raffat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Umer Raffat Today - Breaking & Trending Today

Pfizer turns focus to new drugs as COVID vaccine revenue falls

Published: May 2, 2023

BioPharma

Source: biopharmadive.com

Related Topics:

David DentonBristol Myers Squibb ZeposiaAlbert BourlaDrug AdministrationArena PharmaceuticalsDive BriefWall StreetBristol Myers SquibbGlobal BloodUmer Raffat

Astellas to acquire eye drug developer Iveric Bio for $5.9B

Published: May 1, 2023

BioPharma

Source: biopharmadive.com

Related Topics:

Stephen BarkerIveric BioJon MillerApellis PharmaceuticalsAstellas PharmaBiopharma DiveUmer Raffat

Gilead Sciences (GILD) Q1 2023 Earnings Call Transcript

Published: April 28, 2023

GILD earnings call for the period ending March 31, 2023.

Source: fool.com

Related Topics:

United StatesTim AndersonAmerica Merrill LynchOlivia Brayer Cantor FitzgeraldMerdad ParseySalveen RichterRandy DickinsonBrian SkorneyRaymond JamesTyler Van Buren CowenCharlie MooreChris SchottGeoff MeachamRyan DeschnerOlivia BrayerMichael YeeRyan Deschner Raymond JamesMerrell BioTyler Van BurenTerence FlynnJohanna MercierHartaj Singh OppenheimerChris Schott JpmorganTerence Flynn Morgan StanleyMohit Bansal

Eli Lilly (LLY) Q1 2023 Earnings Call Transcript

Published: April 28, 2023

LLY earnings call for the period ending March 31, 2023.

Source: fool.com

Related Topics:

North CarolinaUnited StatesResearch Triangle ParkPuerto RicoSaudi ArabiaBoone CountySan AntonioPatrick JonssonChris SchottMike SpringnetherDave RicksGeoff MeachamDavid RisingerAmerica Merrill LynchTim AndersonSeamus Fernandez GuggenheimEvan SeigermanEli LillyJoe FletcherLauren ZierkeChris Schott JpmorganTerence Flynn Morgan StanleySeamus FernandezMohit BansalKerry Holford

Vaxcyte strengthens case for experimental pneumococcal vaccine

Published: April 17, 2023

BioPharma

Source: biopharmadive.com

Related Topics:

Jon MillerDavid RisingerDrug AdministrationDive BriefWall StreetUmer RaffatJefferie Roger SongClinical Trials